Back to BlackRock, Inc. BlackRock, Inc.

AVTXAVTX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in AVALO THERAPEUTICS INC

BlackRock, Inc. holds 4.4M shares of AVTX (AVALO THERAPEUTICS INC), worth $80.7M as of 2026-Q2. The position was increased (+1234.7% shares). AVTX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$80.7M

Current Shares

4.4M

Total Value Change

+$79.7M

Total Shares Change

+4.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.4M
+1234.7%
$80.7M0.0%$18.48
48
2026-Q1
Increased
327,082
+12.9%
$4.9M0.0%$18.85
30
2025-Q4
Increased
289,571
+87.7%
$5.3M0.0%$17.81
42
2025-Q3
Decreased
154,251
-1.1%
$2M0.0%$13.02
0
2025-Q2
Increased
155,899
+16.6%
$777,9360.0%$4.78
20
2025-Q1
Increased
133,726
+0.4%
$1.1M0.0%$8.46
17
2024-Q4
New
133,235
-
$989,9360.0%$7.80
38

Other major holders of AVTX: FMR LLC, STATE STREET CORP, FARALLON CAPITAL MANAGEMENT, L.L.C., Point72 Asset Management, L.P., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used